ID
19136
Beschrijving
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS; ODM derived from: https://clinicaltrials.gov/show/NCT00168766
Link
https://clinicaltrials.gov/show/NCT00168766
Trefwoorden
Versies (1)
- 07-12-16 07-12-16 -
Geüploaded op
7 december 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Relapse Recent
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0277556
- UMLS CUI [1,2]
- C0332185
Beschrijving
Immunosuppressive Agents Multiple Sclerosis
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C0026769
Beschrijving
Major Depressive Disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C1269683
Beschrijving
severe reaction Adrenal Cortex Hormones
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3242604
- UMLS CUI [1,2]
- C0001617
Beschrijving
Pregnancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
Beschrijving
Diabetes Mellitus | Substance Dependence
Datatype
boolean
Alias
- UMLS CUI [1]
- C0011849
- UMLS CUI [2]
- C0038580
Beschrijving
Hypersensitivity Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0013230
Similar models
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
- StudyEvent: Eligibility
C0919936 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,2])
C0001617 (UMLS CUI [1,2])
C0038580 (UMLS CUI [2])
C0013230 (UMLS CUI [1,2])